Katy Garner
Nurse Practitioner · Pulaski, TNNPI 1821330424
Payments from drug & device makers
Across 138 payments — averaging $18.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$336
- AbbVie$288
- Pfizer$252
- Novo Nordisk$150
- GSK$146
- E.r. Squibb & Sons, L.L.C.$142
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,50896%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 20 | $336 |
| AbbVie | 15 | $288 |
| Pfizer | 19 | $252 |
| Novo Nordisk | 8 | $150 |
| GSK | 8 | $146 |
| E.r. Squibb & Sons, L.L.C. | 6 | $142 |
| Vanda Pharmaceuticals Inc. | 5 | $141 |
| Astellas Pharma US Inc | 2 | $123 |
| Scilex Pharmaceuticals Inc. | 4 | $85 |
| Mylan Specialty L.p. | 5 | $82 |
| Aimmune Therapeutics, Inc. | 4 | $81 |
| Dexcom, Inc. | 4 | $80 |
| Medtronic | 5 | $76 |
| Alkermes, Inc. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Exact Sciences | 2 | $40 |
| Lundbeck LLC | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Amgen | 2 | $37 |
| Lilly USA, LLC | 3 | $36 |
| Merck | 2 | $35 |
| Bayer | 1 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Boehringer Ingelheim | 2 | $26 |
| Qorumpartners | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Ardelyx, Inc. | 1 | $24 |
| Abbott | 1 | $23 |
| Johnson & Johnson | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
How this compares
$2,608 in reported general payments places this provider in the 80th percentile of 2,662 nurse practitioner providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 126 | $113,993 |
| OzempicSemaglutide | 87 | $90,351 |
| FarxigaDapagliflozin Propanediol | 128 | $88,359 |
| LinzessLinaclotide | 63 | $44,572 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 61 | $42,979 |
| TrulicityDulaglutide | 32 | $33,068 |
| VraylarCariprazine Hcl | 20 | $31,696 |
| Nurtec OdtRimegepant Sulfate | 23 | $31,696 |
| RexultiBrexpiprazole | 20 | $29,442 |
| UbrelvyUbrogepant | 24 | $26,191 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 35 | $24,520 |
| EliquisApixaban | 23 | $21,923 |
| XareltoRivaroxaban | 25 | $21,632 |
| TradjentaLinagliptin | 26 | $16,038 |
| MyrbetriqMirabegron | 21 | $13,523 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat | $26 | $139,163163 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $336 | $112,879163 claims |
| AbbVieLinzess, Vraylar, Ubrelvy | $288 | $102,458107 claims |
| Novo NordiskOzempic | $150 | $90,35187 claims |
| PfizerNurtec Odt, Eliquis | $252 | $53,61946 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Insulin Lispro | $36 | $46,08566 claims |
| GSKTrelegy Ellipta | $146 | $42,97961 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $25 | $29,44220 claims |
| Johnson & JohnsonXarelto | $19 | $21,63225 claims |
| Astellas Pharma US IncMyrbetriq | $123 | $13,52321 claims |
| BayerKerendia | $28 | $6,86511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,662 nurse practitioner providers in Tennessee.
Other nurse practitioner in Pulaski
- Amy HatcherMurfreesboro$1.1M
- Karen RodenKnoxville$265K
- Susan UtleyNashville$194K
- Whitney EricksonMemphis$159K
- Erica HembreeKnoxville$125K
- Brooke FaughtNashville$89K
- Lauren WelchNashville$71K
- Cara StoutKingsport$71K
- S Marie HamiltonOoltewah$64K
- Cynthia WilsonChattanooga$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.